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If resistance carries a within-host growth cost,
a sensitive cell benefits if it co-colonises a resistant-cell
carrier, but not if it co-colonises a sensitive-cell carrier.
 
Thus, sensitive cells have a fitness advantage
when carriers tend to be colonised by resistant cells.
With co-colonisation
and differential within-host growth
A resistant cell benefits from antibiotic treatment 
if it co-colonises a sensitive-cell carrier,
but not if it co-colonises a resistant-cell carrier.
 
Thus, resistant cells have a fitness advantage


















When hosts cannot be co-colonised, bacteria can
only gain fitness by exploiting uncolonised hosts.
 
Therefore, whether colonised hosts carry
sensitive or resistant bacteria has no impact








































































1st colonisation 2nd colonisation 3rd colonisation
The first colonisation
fills the host niche,






“knock out” and replace
one half of the existing carriage.
The first colonisation
fills the host niche.
Subsequent colonisations add to existing 
carriage, subject to carrying capacity.
Colonisations are




























































































Antibiotic consumption rate (courses per person per year)
E. coli / Aminopenicillins E. coli / Fluoroquinolones S. pneumoniae / Macrolides S. pneumoniae / Penicillins
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Serotypes circulate in . . .
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Knockout!model4,28)—)In)a)population)of)N)hosts)indexed)by)! ∈ 1. .! ,)there)are)!!)nonTcarriers,)!!)sensitiveTstrain)carriers,)!!)resistantTstrain)carriers,)and)!!")dual)carriers;)we)notate)host)i’s)state)as)ℎ! ∈ X, S,R, SR .)The)following)hostTstate)transitions)occur)as)inhomogeneous)Poisson)point)processes)at)the)specified)perThost)rates:)! !! !!!(!"#!$%$&"!!"#$%&!!"#"$%&'(%"$))! !! !!!(!"#$#%&'%!!"#$%&!!"#"$%&'(%"$))! !!! !"!!(!"#!$%$&"!!"#$%&!!" − !"#"$%&'(%"$))
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! !!! !"!!(!"#$#%&'%!!"#$%&!!! − !"#"$%&'(%"$))!" !!!!! !!!(!"#$!#%&!!"!!"#$#%&'%!!"#$%&))!" !!!!! !!!(!"#$!#%&!!"!!"#!$%$&"!!"#$%&))! !!! !!!!(!"#!$%$&" − !"#$%&!!"##$%#!!"#$%$&!#!!"!!!"#$%"&$))! !!!!! !!!!(!"#$#%&'% − !"#$%&!!"##$%#!!"#$%$&!#))!" !!!!! !!!!(!"#$!!"##$%#!!"#$%$&!#))!" !!!!! !!!! !"#$!!"##$%#!!"#$!%#&! !.)For)example,)nonTcarriers)(X))become)sensitiveTstrain)carriers)(S))at)rate)!!,)and)so)on.)Above,)!! = ! !!!!!!!"! )is)the)sensitive)strain’s)force)of)infection,)!! = !(1 − !) !!!!!!!"! )is)the)resistant)strain’s)force)of)infection,)β)is)the)transmission)rate,)c)is)the)transmission)cost)of)resistance,)k)is)the)relative)efficiency)of)coTcolonisation,)u)is)the)natural)clearance)rate,)and)τ)is)the)treatment)rate.)In)this)model,)the)resistance)prevalence)is)! = (!! +!!!!")/(!! + !! + !!").))
Mixed@carriage!model)—)In)a)population)of)N)hosts)indexed)by)! ∈ [1. .!])as)above,)host)
i’s)state)is) !! , !! ,)where)!! ≥ 0)is)host)i’s)carriage)of)the)sensitive)strain)and)!! ≥ 0)is)host)i’s)carriage)of)the)resistant)strain.)In)a)nonTcarrier,)!! = !! = 0,)while)in)a)carrier,)!! + !! = 1.)We)model)transmission,)clearance,)and)treatment)events)as)inhomogeneous)Poisson)point)processes,)while)withinThost)strain)growth)is)updated)in)each)host)at)regular)discrete)time)steps.)The)following)hostTstate)transitions)occur)at)the)specified)perThost)rates:)!! , !! !!!! !!!!!!!!!!!, !!!!!!!!! !!!!(!"#!$%$&"!!"#$%&!!"#$%&'%%'($))!! , !! !!!! !!!!!!!!!, !!!!!!!!!!! !!!!(!"#$#%&'%!!"#$%&!!"#$%&'%%'($))!! , !! !!!!! 0,0 !!!!(!"#$!"#$%))!! , !! !!!!! 0,0 if!!! = 00,1 if!!! > 0 !!! !"#$!%#&! !.)For)example,)a)host)with)state)(!! , !!) = 0,1 )changes)state)to) !! , !! = ( !!!!, !!!!))at)rate)!!!!,)and)so)on.)Above,)!! = 1)if) !! , !! = (0,0))and)!! = !)otherwise;)ι)is)the)germ)size;)and)forceTofTinfection)terms)are)!! = !max !!"#, !!! /!)and)!! = !(1 − !)max !!"#, !!! /!,)where)we)can)set)!!"# = 1)to)effectively)assume)there)is)always)at)least)one)carrier)of)each)strain)to)avoid)stochastic)elimination)of)strains27,)or)set)!!"# = 0)to)not)do)this.)The)resistance)prevalence)is)! = !!! / (!! + !!! ).))Updates)to)withinThost)strain)growth)happen)to)all)hosts)simultaneously)at)intervals)of)∆t)(unless)otherwise)specified,)∆t)=)0.001)mo–1),)as)follows.)For)each)host,)any)strains)for)which)carriage)is)less)than)fmin)are)set)to)zero)(we)primarily)use)fmin)=)3×10T5)to)keep)strains)from)persisting)when)they)reach)low)frequencies,)but)can)set)fmin)=)0)to)allow)them)to)remain)at)any)frequency)until)treatment)and/or)natural)clearance)occurs).)Then)the)sensitive)strain)in)each)carrier)grows)by)a)factor)!! = !!!" ,)where)ws)is)the)sensitive)strain’s)relative)growth)rate)(such)that)ws)=)1)translates)to)no)differential)withinThost)
 17"
growth).)Finally,)each)colonised)host’s)total)carriage)is)normalised)so)that)!! + !! = 1.)That)is,)every)∆t)units)of)time,)each)colonised)host)undergoes)the)transition)!! , !! → !!! !!!!! !! + ! !! , ! !!!!! !! + ! !! !,)where) ! ! = ! if!! ≥ !!"#0 if!! < !!"#!.)In)our)implementation,)we)calculate)the)forceTofTinfection)terms)and)the)number)of)events)of)each)type)between)time)t)and)t)+)∆t)during)the)“updating”)step,)then)execute)each)event)in)a)random)order.)
!
Systems!of!ODEs)—)The)knockout)and)mixedTcarriage)models)can)be)approximated)using)ODEs)(Supplementary)Note)1).)Following)previous)work4,28,)the)knockout)model)is)implemented)as)!"!" = !!!"!! − ! + ! ! − !" 1 − ! !!"!! + !"!!"!!2 )!"!" = ! 1 − ! !!"!! − !" − !"!!"!! + !" 1 − ! !!"!!2 + !")!"!" = !" 1 − ! !!"!! + !"!!"!! − ! + ! ! − !"!!"!!2 − !" 1 − ! !!"!!2 )! = 1 − ! − ! − !!.)) ) ) ) ) ) ) ) ) ) (1))Here,)S)is)the)fraction)of)sensitiveTstrain)carriers)in)the)population;)R)is)the)fraction)of)resistantTstrain)carriers;)D)is)the)fraction)of)dual)carriers)(i.e.,)SR)hosts);)and)X)is)the)fraction)of)nonTcarriers.)Here,)Stot)=)S)+)D/2)and)Rtot)=)R)+)D/2)give)the)effective)population)burden)of)sensitiveT)and)resistantTstrain)colonisation,)respectively,)and)the)resistance)prevalence)is)ρ)=)Rtot/(1–X).)The)parameters)!, !, !, !,)and)k)correspond)to)those)used)in)the)individualTbased)implementation)of)the)knockout)model,)described)above.))Similarly,)the)mixedTcarriage)model)(in)the)absence)of)differential)withinThost)growth))can)be)approximated)using)the)following)system)of)ODEs:)!"!" = !!!"!! − ! + ! ! − !" 1 − ! !!"!!)!"!" = ! 1 − ! !!"!! − !" − !"!!"!! + !(!! + !!)!)!!!!" = !" 1 − ! !!"!! − ! + ! !! )!!!!" = !"!!"!! − ! + ! !!)! = 1 − ! − ! − !! − !!!.)) ) ) ) ) ) ) ) ) ) ) (2))Here,)the)compartment)SR)captures)the)fraction)of)the)population)predominantly)colonised)with)sensitive)bacteria,)but)also)carrying)a)small)amount)of)resistant)bacteria)that)are)carried)in)insufficient)quantity)to)transmit,)and)Stot)=)S)+)SR)gives)the)effective)population)burden)of)sensitiveTstrain)colonisation.)Similarly,)the)compartment)RS)captures)the)fraction)of)the)population)predominantly)colonised)with)resistant)bacteria,)but)also)carrying)a)small)amount)of)sensitive)bacteria)that)are)carried)in)insufficient)
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quantity)to)transmit,)and)Rtot)=)R)+)RS)gives)the)effective)population)burden)of)resistantTstrain)colonisation.)The)overall)resistance)prevalence)is)!)=)Rtot/(1–X).)The)parameters)!, !, !, !,)and)k)correspond)to)those)used)in)the)individualTbased)implementation)of)the)mixedTcarriage)model,)described)above.)))Finally,)the)mixedTcarriage)model)with)differential)withinThost)growth)can)be)approximated)with)ODEs)by)adding))“intermediate”)compartments)between)RS!and!SR:)!"!" = !!!"!! − ! + ! ! − !"(1 − !)!!"!! + !!!! )!"!" = !(1 − !)!!"!! − !" + ! !! + !!!!!! + !! − !"!!"!!)!!!!" = !"(1 − !)!!"!! − ! + ! !! − !!!! + !!!)!!!!" = − ! + ! !! − !!! + !!!!!!!!!!!!!!for!all!! ∈ [1. .!])!!!! ≡ !!)!!!!" = !"!!"!! − ! + ! !! − !!!)! = 1 − ! − ! − !! − !!!!!! − !!!.)) ) ) ) ) ) ) ) ) ) ) (3))Here,)there)are)Z)“intermediate”)compartments)between)RS)and)SR,)labelled)D1)through)
DZ)(we)use)Z)=)7;)see)Supplementary)Note)1)for)a)graphical)illustration)of)the)dynamics)of)these)intermediate)compartments).)Here,)b)determines)the)withinThost)growth)rate)of)the)sensitive)strain)relative)to)the)resistant)strain,)setting)the)rate)at)which)individuals)move)from)the)RS)compartment)through)intermediate)compartments)and)finally)through)to)S)as)the)resistant)strain)is)gradually)outcompeted)by)the)sensitive)strain.)A)separate)parameter)b0)sets)the)rate)of)the)final)transition)from)SR)to)S.)In)practice,)we)set)!! = !! !,)which)for)Z)=)7)and)! = 0.001)corresponds)to)the)resistant)strain)effectively)becoming)lost)once)its)withinThost)frequency)drops)below)fmin)=)3×10T5)(Supplementary)Note)1).)The)parameters)b)and)b0)replace)the)parameters)ws)and)fmin)from)the)individualTbased)implementation)of)the)mixedTcarriage)model,)above;)all)other)parameters)(i.e.)!, !, !, !,)and)k))correspond)to)those)used)in)the)individualTbased)implementation.))Notating)the)fraction)of)a)host’s)bacterial)carriage)that)is)resistant)as)!!)for)a)host)with)state)Y,)we)assume)that)!!! = !!!!,)!!! = !!!!,)and)that)intermediate)compartments)are)evenly)spaced)between)these)points)on)a)logistic)curve,)i.e.)that)!!! = !!!!"# !(!) ,)where)! ! = log(!) !!!!! − 1 .)We)assume)that)individuals)in)compartment)Dv)transmit)the)resistant)strain)a)fraction)!!! )of)the)time)and)transmit)the)sensitive)strain)a)fraction)1 − !!! )of)the)time,)but)that)RS)individuals)only)transmit)the)resistant)strain)and)SR)individuals)only)transmit)the)sensitive)strain.)Ignoring)transmission)of)the)minor)strain)for)these)two)host)types)maintains)consistency)with)equations)(2))and)maintains)structural)neutrality)for)equivalent)strains)in)equations)(3).)Accordingly,)in)the)model)above,)!!"! = ! + !! + !!(1 − !!!)! )and)!!"! = ! + !! + !!!!!! .)Note)that)the)
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mixedTcarriage)model)without)differential)withinThost)growth)can)be)recovered)from)the)above)model)by)setting)! = !! = 0;)in)model)fitting,)when)we)allow)differential)growth)(i.e.)b)>)0))we)assume)that)this)accounts)for)the)cost)of)resistance,)and)accordingly)set)c)=)0.)In)this)model,)the)overall)resistance)prevalence)is)!)=)Rtot/(1–X).)
!
Initial!conditions!and!solutions)—)For)all)individualTbased)model)simulations,)we)assume)that)5%)of)hosts)are)colonised)at)the)beginning)of)the)simulation)by)a)single)randomlyTselected)strain,)and)run)the)simulation)for)100–400)years,)taking)the)average)state)over)the)last)50–100)years)as)the)equilibrium)state.)IndividualTbased)models)are)simulated)in)C++.)All)ODE)models)are)solved)by)setting)singleTcarriage)compartments)(S)and)R))equal)to)0.001)and)all)dualTcarriage)compartments)to)0,)then)integrating)the)systems)of)ordinary)differential)equations)numerically)in)C++)using)the)Runge–Kutta)Dormand–Prince)method)until)they)reach)equilibrium.))Model)fitting)to)resistance)prevalence)in)commensal)bacteria))In)the)source)data2,)antibiotic)consumption)rates)are)given)in)defined)daily)doses)(DDD))per)thousand)people)per)day;)we)convert)these)to)overall)treatment)rates)by)assuming)that)10)DDD)comprise)one)treatment)course)for)penicillin7)and)fluoroquinolones,)while)7)DDD)comprise)one)treatment)course)for)macrolides.))We)use)Bayesian)inference)to)fit)the)model)to)empirical)data,)using)differential)evolution)Markov)chain)Monte)Carlo)(DETMCMC48))to)estimate)the)posterior)distribution)of)model)parameters.)We)assume)that)the)number)of)resistant)isolates)observed)in)a)given)country)is)binomially)distributed;)the)probability)of)observing)a)resistant)isolate)is)equal)to)the)resistance)prevalence)ρ)predicted)by)the)model,)plus)some)additional)dispersion)modelled)using)a)[0,1]–truncated)normal)distribution.)Modelling)the)“true”)resistance)prevalence)as)a)random)variable)allows)us)to)account)for)betweenTcountry)variation)in)resistance)prevalence)not)captured)by)our)dynamic)model.)As)we)assume)that)the)only)parameter)that)varies)between)European)countries)is)the)rate)of)antibiotic)consumption,)this)additional)variation)is)intended)to)account)for)other)factors)that)may)vary)between)countries,)whether)they)are)explicitly)part)of)the)model)structure)(e.g.)transmission)rates)varying)from)country)to)country))or)not)(e.g.)differences)in)laboratory)procedures,)population)structure,)or)prescription)patterns)from)country)to)country).))For)a)given)model)fit)with)parameters)!,)suppose)that)country)m)(where)countries)are)numbered)1)to)M))has)antibiotic)treatment)rate)!!)and)reports)that)rm)out)of)nm)isolates)are)resistant.)Over)all)M)countries,)these)data)are)denoted)! = (!!, !!,… , !!),)! =(!!, !!,… , !!),)and)! = !!, !!,… , !! ,)respectively.)We)also)have)!(!))and)!(!),)which)are)the)lower)and)upper)bounds)for)carriage)prevalence)in)any)country)(see)below).)Together,)!, !,!,!(!))and)!(!))are)the)data)to)which)the)model)is)being)fit,)and)model)parameters)are)! = (!, !, !, !, !,!).)(Note)that,)for)certain)data)sets,)not)all)of)the)parameters)in)!)are)permitted)to)vary;)specifically,)we)assume)u)=)1)when)fitting)S.!
pneumoniae)for)consistency)with)previous)studies,)and)we)only)allow)one)of)c)and)b)to)vary)at)a)time)in)order)to)contrast)these)two)alternative)costs)of)resistance.))Suppose)that,)for)a)given)treatment)rate)!! ,)the)model)predicts)a)resistance)prevalence)of)!(!!|!))and)a)prevalence)of)carriage)!(!!|!).)Then,)the)likelihood)of)the)model)fit)is)
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ℒ !, !,!,!(!),!(!)|! = ! !! ,!(!),!(!)|! !ℛ !! , !! , !!|!! !,)which)is)constructed)of)two)components)that)are)evaluated)for)each)country.)The)first)component,)! !! ,!(!),!(!)|! = 1exp!(−1000) !!!! if!!(!) ≤ ! !! !) ≤ !(!)otherwise !,)heavily)penalises)any)model)fit)which)predicts)that)any)country)has)a)prevalence)of)carriage)not)within)the)bounds)[! ! ,! ! ])and)is)used)to)prevent)the)modelTfitting)process)from)predicting)an)unrealistic)carriage)prevalence)for)any)country.)The)second)component,)ℛ !! , !! , !!|! = ! ! ! = !(!!|!),! = ! ! !ℬ !! ! = !! , ! = ! !d!!! !,)assigns)a)likelihood)to)the)modelTpredicted)resistance)prevalence)!(!!|!))given)that)country)m)has)reported)that)!!)of)!!)bacterial)isolates)are)resistant.)Above:)! ! !,! =! ! !,! ! 1 !,! − ! 0 !,! )is)the)probability)density)function)(PDF))of)a)truncated)normal)distribution)with)bounds)0)and)1,)where)! ! !,! = !!!!! exp − !!! !!!! )is)the)untruncated)normal)PDF)and)! ! !,! = !! (1 +erf !!!! ! ))is)the)untruncated)normal)cumulative)distribution)function)(CDF);)and)ℬ ! !, ! = !! !!(1 − !)!!! )is)the)binomial)distribution)probability)mass)function)(PMF),)such)that)the)integral)calculates)a)weighted)likelihood)over)all)possible)“true”)resistance)prevalences)x.)The)parameter)! ! )of)the)truncated)normal)distribution)is)fit)as)one)of)the)parameters)of)the)model)so)that)betweenTcountry)variation)is)estimated)separately)for)each)alternative)model.)))Priors)used)for)model)fitting,)posterior)distributions)from)model)fitting,)and)further)details)of)MCMC)can)be)found)in)Supplementary)Note)4.)Note)that)since)we)are)only)fitting)to)the)measured)resistance)prevalence)in)each)European)country)and)to)a)fixed)range)of)carriage)prevalence,)the)values)of)certain)parameters)are)difficult)to)identify,)particularly)for)the)knockout)model.))














Lancet)365,)579–587)(2005).)2.) European)Centre)for)Disease)Prevention)and)Control.)Antimicrobial)consumption)rates)by)country.)(2018).)Available)at:)http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/esacTnetTdatabase/Pages/AntimicrobialTconsumptionTratesTbyTcountry.aspx.))3.) European)Centre)for)Disease)Prevention)and)Control.)Data)from)the)ECDC)Surveillance)Atlas)T)Antimicrobial)resistance.)(2016).)Available)at:)https://ecdc.europa.eu/en/antimicrobialTresistance/surveillanceTandTdiseaseTdata/dataTecdc.)(Accessed:)24th)February)2018))4.) Colijn,)C.)et!al.)What)is)the)mechanism)for)persistent)coexistence)of)drugTsusceptible)and)drugTresistant)strains)of)Streptococcus!pneumoniae?)J.!R.!Soc.!
Interface)7,)905–919)(2010).)5.) Hardin,)G.)The)competitive)exclusion)principle.)Science!(80@.!).)131,)1292–1297)(1960).)6.) Cobey,)S.)et!al.)Host)population)structure)and)treatment)frequency)maintain)balancing)selection)on)drug)resistance.)J.!R.!Soc.!Interface)14,)20170295)(2017).)7.) Lehtinen,)S.)et!al.)Evolution)of)antibiotic)resistance)is)linked)to)any)genetic)mechanism)affecting)bacterial)duration)of)carriage.)Proc.!Natl.!Acad.!Sci.)114,)1075–1080)(2017).)8.) Austin,)D.)J.,)Kristinsson,)K.)G.)&)Anderson,)R.)M.)The)relationship)between)the)volume)of)antimicrobial)consumption)in)human)communities)and)the)frequency)of)resistance.)Proc.!Natl.!Acad.!Sci.)96,)1152–1156)(1999).)9.) World)Health)Organization.)United)Nations)highTlevel)meeting)on)antimicrobial)resistance.)(2016).)Available)at:)http://www.who.int/mediacentre/events/2016/antimicrobialTresistance/en/%5Cnhttp://www.who.int/antimicrobialTresistance/events/UNGATmeetingTamrTsept2016/en/.))10.) O’Neill,)J.)Tackling)drugTresistant)infections)globally:)final)report)and)recommendations.)(2016).)Available)at:)https://amrTreview.org/.))11.) Kamng’ona,)A.)W.)et!al.)High)multiple)carriage)and)emergence)of)Streptococcus!
pneumoniae)vaccine)serotype)variants)in)Malawian)children.)BMC!Infect.!Dis.)15,)234)(2015).)12.) Turner,)P.)et!al.)Improved)detection)of)nasopharyngeal)cocolonization)by)multiple)pneumococcal)serotypes)by)use)of)latex)agglutination)or)molecular)serotyping)by)microarray.)J.!Clin.!Microbiol.)49,)1784–1789)(2011).)13.) MartinezTMedina,)M.)et!al.)Molecular)diversity)of)Escherichia!coli)in)the)human)gut:)new)ecological)evidence)supporting)the)role)of)adherentTinvasive)E.!coli)(AIEC))in)Crohn’s)disease.)Inflamm!Bowel!Dis)15,)872–882)(2009).)14.) Mongkolrattanothai,)K.)et!al.)Simultaneous)carriage)of)multiple)genotypes)of)
Staphylococcus!aureus)in)children.)J.!Med.!Microbiol.)60,)317–322)(2011).)15.) Gordon,)D.)M.,)O’Brien,)C.)L.)&)Pavli,)P.)Escherichia)coli)diversity)in)the)lower)intestinal)tract)of)humans.)Environ.!Microbiol.!Rep.)7,)642–648)(2015).)16.) Chaban,)B.)et!al.)Characterization)of)the)Upper)Respiratory)Tract)Microbiomes)of)
 24"
Patients)with)Pandemic)H1N1)Influenza.)PLoS!One)8,)1–11)(2013).)17.) Ederveen,)T.)H.)A.)et!al.)Haemophilus)is)overrepresented)in)the)nasopharynx)of)infants)hospitalized)with)RSV)infection)and)associated)with)increased)viral)load)and)enhanced)mucosal)CXCL8)responses.)Microbiome)6,)1–13)(2018).)18.) Lozupone,)C.)A.,)Stombaugh,)J.)I.,)Gordon,)J.)I.,)Jansson,)J.)K.)&)Knight,)R.)Diversity,)stability)and)resilience)of)the)human)gut)microbiota.)Nature)489,)220–230)(2012).)19.) Negri,)M.)C.,)Lipsitch,)M.,)Blázquez,)J.,)Levin,)B.)R.)&)Baquero,)F.)ConcentrationTdependent)selection)of)small)phenotypic)differences)in)TEM)betaTlactamaseTmediated)antibiotic)resistance.)Antimicrob.!Agents!Chemother.)44,)2485–91)(2000).)20.) Wargo,)A.)R.,)Huijben,)S.,)de)Roode,)J.)C.,)Shepherd,)J.)&)Read,)A.)F.)Competitive)release)and)facilitation)of)drugTresistant)parasites)after)therapeutic)chemotherapy)in)a)rodent)malaria)model.)Proc.!Natl.!Acad.!Sci.)104,)19914–19919)(2007).)21.) Melnyk,)A.)H.,)Wong,)A.)&)Kassen,)R.)The)fitness)costs)of)antibiotic)resistance)mutations.)Evol.!Appl.)8,)273–283)(2015).)22.) Smani,)Y.)et!al.)In)vitro)and)in)vivo)reduced)fitness)and)virulence)in)ciprofloxacinTresistant)Acinetobacter)baumannii.)Clin.!Microbiol.!Infect.)18,)1–4)(2012).)23.) Birch,)L.)C.)The)meanings)of)competition.)Am.!Nat.)91,)5–18)(1957).)24.) Hastings,)I.)M.)Complex)dynamics)and)stability)of)resistance)to)antimalarial)drugs.)
Parasitology)132,)615–624)(2006).)25.) Ayala,)F.)J.)Competition)between)species:)frequency)dependence.)Science!(80@.!).)
171,)820–824)(1971).)26.) Ayala,)F.)J.)&)Campbell,)C.)A.)FrequencyTdependent)selection.)Annu.!Rev.!Ecol.!Syst.)
5,)115–138)(1974).)27.) Cobey,)S.)&)Lipsitch,)M.)Niche)and)neutral)effects)of)acquired)immunity)permit)coexistence)of)pneumococcal)serotypes.)Science!(80@.!).)335,)1376–1380)(2012).)28.) Lipsitch,)M.,)Colijn,)C.,)Cohen,)T.,)Hanage,)W.)P.)&)Fraser,)C.)No)coexistence)for)free:)Neutral)null)models)for)multistrain)pathogens.)Epidemics)1,)2–13)(2009).)29.) Sinervo,)B.)&)Lively,)C.)M.)The)rockTpaperTscissors)game)and)the)evolution)of)alternative)male)strategies.)Nature)380,)240–243)(1996).)30.) Gigord,)L.)D.)B.,)Macnair,)M.)R.)&)Smithson,)A.)Negative)frequencyTdependent)selection)maintains)a)dramatic)flower)color)polymorphism)in)the)rewardless)orchid)Dactylorhiza!sambucina)(L.))Soò.)Proc.!Natl.!Acad.!Sci.)98,)6253–6255)(2001).)31.) Rainey,)P.)B.)&)Travisano,)M.)Adaptive)radiation)in)a)heterogeneous)environment.)
Nature)394,)69–72)(1998).)32.) Wale,)N.)et!al.)Resource)limitation)prevents)the)emergence)of)drug)resistance)by)intensifying)withinThost)competition.)Proc.!Natl.!Acad.!Sci.)201715874)(2017).)doi:10.1073/pnas.1715874115)33.) Lewnard,)J.)A.)et!al.)Impact)of)antimicrobial)treatment)for)acute)otitis)media)on)carriage)dynamics)of)penicillinTsusceptible)and)penicillin–nonTsusceptible)Streptococcus)pneumoniae.)J.!Infect.!Dis.)jiy343)(2018).)doi:10.1093/infdis/jiy343/5033369)34.) Andersson,)D.)I.)The)biological)cost)of)mutational)antibiotic)resistance:)any)practical)conclusions?)Current!Opinion!in!Microbiology)9,)461–465)(2006).)
 25"
35.) Andersson,)D.)I.)&)Hughes,)D.)Antibiotic)resistance)and)its)cost:)Is)it)possible)to)reverse)resistance?)Nat.!Rev.!Microbiol.)8,)260–271)(2010).)36.) Flasche,)S.)et!al.)The)impact)of)specific)and)nonTspecific)immunity)on)the)ecology)of)Streptococcus!pneumoniae)and)the)implications)for)vaccination.)Proc.!R.!Soc.!B!
Biol.!Sci.)280,)20131939)(2013).)37.) MacFadden,)D.)R.,)McGough,)S.)F.,)Fisman,)D.,)Santillana,)M.)&)Brownstein,)J.)S.)Antibiotic)resistance)increases)with)local)temperature.)Nat.!Clim.!Chang.)8,)510–514)(2018).)38.) Dietz,)K.)Epidemiologic)interference)of)virus)populations.)J.!Math.!Biol.)8,)291–300)(1979).)39.) Gupta,)S.,)Swinton,)J.)&)Anderson,)R.)M.)Theoretical)studies)of)the)effects)of)heterogeneity)in)the)parasite)population)on)the)transmission)dynamics)of)malaria.)Proc.!R.!Soc.!B!Biol.!Sci.)256,)231–238)(1994).)40.) Lipsitch,)M.)Vaccination)against)colonizing)bacteria)with)multiple)serotypes.)Proc.!
Natl.!Acad.!Sci.)94,)6571–6576)(1997).)41.) Blanquart,)F.,)Lehtinen,)S.)&)Fraser,)C.)An)evolutionary)model)to)predict)the)frequency)of)antibiotic)resistance)under)seasonal)antibiotic)use,)and)an)application)to)Streptococcus!pneumoniae.)Proc.!R.!Soc.!B!Biol.!Sci.)284,)20170679)(2017).)42.) Colijn,)C.)&)Cohen,)T.)How)competition)governs)whether)moderate)or)aggressive)treatment)minimizes)antibiotic)resistance.)Elife)4,)1–29)(2015).)43.) Smith,)E.)E.)et!al.)Genetic)adaptation)by)Pseudomonas!aeruginosa)to)the)airways)of)cystic)fibrosis)patients.)Proc.!Natl.!Acad.!Sci.)103,)8487–8492)(2006).)44.) Yang,)L.)et!al.)Evolutionary)dynamics)of)bacteria)in)a)human)host)environment.)
Proc.!Natl.!Acad.!Sci.)108,)7481–7486)(2011).)45.) Lehtinen,)S.)et!al.)Mechanisms)that)maintain)coexistence)of)antibiotic)sensitivity)and)resistance)also)promote)high)frequencies)of)multidrug)resistance.)bioRxiv)













































of	within-host	strain	growth		In	this	section,	we	formally	show	that	when	!"#$ = &"#$ = 0,	)* = 1,	,	and	Δ.	are	arbitrarily	close	to	zero,	and	the	population	size	N	is	infinite,	the	individual-based	and	ODE	implementations	of	the	mixed-carriage	model	are	equivalent.	Differential	within-host	strain	growth	is	discussed	in	section	1.2.		Briefly,	the	equivalence	of	the	individual-based	and	ODE	implementations	can	be	seen	by	interpreting	the	rates	of	change	in	the	system	of	ODEs	described	by	equation	(2)	in	the	main	text	as	rates	of	transitions	between	host	states,	verifying	that	these	transition	rates	are	equivalent	to	the	event	rates	used	in	the	individual-based	implementation,	and	noting	that	events	have	an	equivalent	impact	upon	hosts	in	the	individual-based	implementation	as	the	transitions	in	the	ODE	implementation	do.		Suppose	that,	in	the	individual-based	mixed-carriage	model	implementation,	we	have:	two	strains,	no	minimum	host	carriage	frequency	(!"#$ = 0),	no	minimum	number	of	carriers	of	each	strain	(&"#$ = 0),	the	germ	size	,	infinitesimally	small,	and	equal	within-host	fitness	for	both	strains	(ws	=	1).	Recall	that	we	denote	host	i	as	ℎ0 = (20, 30),	where	20 	is	the	host’s	sensitive-strain	carriage	and	30 	is	the	host’s	resistant-strain	carriage.	Suppose	further	that	at	some	time	t	there	are	N	hosts	in	total,	and	that	of	these	N	hosts,	56	hosts	are	non-carriers	(i.e.	56	hosts	have	host	state	ℎ0 = (0,0)),	57	hosts	carry	only	
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the	sensitive	strain	(ℎ0 = (1,0)),	58	hosts	carry	only	the	resistant	strain	(ℎ0 = (0,1)),	579 	hosts	carry	the	sensitive	strain	plus	a	very	small	amount	of	the	resistant	strain	(ℎ0 =(1 − ;0, ;0),where	all	;0 	are	infinitesimally	close	to	zero),	and	58< 	hosts	carry	the	resistant	strain	plus	a	very	small	amount	of	the	sensitive	strain	(ℎ0 = (;0, 1 − ;0)).	We	are	assuming	that,	at	time	t,	all	hosts	can	be	classified	as	one	of	these	five	host	types,	so	5 = 56 + 57 + 58 + 579 + 58< .	Since	all	;0 	terms	are	infinitesimally	small	and	&"#$ = 0,	the	force	of	infection	terms	>* = ?max &"#$, 200 /5	and	>D = ?(1 −E)max &"#$, 300 /5	can	be	simply	written	>* = F G<HG<9G 	and	>D = F IJK G9HG9<G .		The	individual-based	model	implementation	proceeds	via	(i)	events	of	transmission,	clearance,	and	treatment	modelled	as	inhomogeneous	Poisson	point	processes,	and	(ii)	updates	to	within-host	strain	growth,	which	occur	regularly	at	time	intervals	of	∆t.	Recall	that	the	updating	step	applies	the	transition		 20, 30 → M*N 20M*N 20 + N 30 , N 30M*N 20 + N 30 	,		to	all	hosts	with	non-zero	carriage,	where		 N P = P if	P ≥ !"#$0 if	P < !"#$			and	M* = )*UV .	Note	that	when	)* = 1	and		fmin	=	0,	this	updating	step	has	no	effect,	so	it	can	be	ignored	for	our	purposes.			Recall	that	the	“events”	in	the	mixed-carriage	model	are		 20, 30 WXYZ [XH\[XH]XH\, ]X[XH]XH\ 				(2^_2`.`a^	2.3P`_	.3P_2b`22`c_)	20, 30 WXYd [X[XH]XH\, ]XH\[XH]XH\ 				(3^2`2.P_.	2.3P`_	.3P_2b`22`c_)	20, 30 		e		 0,0 				(Ef^P3P_E^)	20, 30 		g		 0,0 if	30 = 00,1 if	30 > 0			 .3^P.b^_. 	.		Recalling	that		j0 = 1	if	 20, 30 = (0,0)	and	j0 = k	otherwise,	we	can	write	out	these	transitions	for	each	of	the	five	host	types,	yielding:		 sensitive	strain	transmission		 		 	 	 							“X”	 0,0 YZ 1,0 	“S”			 	 	 	 							“S”	 1,0 lYZ 1,0 	“S”		 		 	 	 							“R”	 0,1 lYZ mnom, nnom ⟺ ;0q, 1 − ;0q 	“RS”			 	 	 										“SR”	 1 − ;0, ;0 lYZ nrsXomnom , sXnom ⟺ 1 − ;0q, ;0q 	“SR”			 	 	 										“RS”	 ;0, 1 − ;0 lYZ sXomnom , nrsXnom ⟺ ;0q, 1 − ;0q 	“RS”	
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resistant	strain	transmission		 		 	 	 							“X”	 0,0 Yd 0,1 	“R”			 	 	 	 							“S”	 1,0 lYd nnom, mnom ⟺ 1 − ;0q, ;0q 	“SR”		 		 	 	 							“R”	 0,1 lYd 0,1 	“R”			 	 	 										“SR”	 1 − ;0, ;0 lYd nrsXnom , sXomnom ⟺ 1 − ;0q, ;0q 	“SR”			 	 	 										“RS”	 ;0, 1 − ;0 lYd sXnom, nrsXomnom ⟺ ;0q, 1 − ;0q 	“RS”	
	
clearance		 		 	 	 							“X”	 0,0 e 0,0 	“X”			 	 	 	 							“S”	 1,0 e 0,0 	“X”		 		 	 	 							“R”	 0,1 e 0,0 	“X”			 	 	 										“SR”	 1 − ;0, ;0 e 0,0 	“X”			 	 	 										“RS”	 ;0, 1 − ;0 e 0,0 	“X”		
treatment		 		 	 	 							“X”	 0,0 g 0,0 	“X”			 	 	 	 							“S”	 1,0 g 0,0 	“X”		 		 	 	 							“R”	 0,1 g 0,1 	“R”			 	 	 										“SR”	 1 − ;0, ;0 g 0,1 	“R”			 	 	 										“RS”	 ;0, 1 − ;0 g 0,1 	“R”	 	 (S1)		where	some	of	the	states	on	the	right-hand	side	of	each	transition	have	been	rewritten	using	;0q,	which	are	arbitrary	values	infinitesimally	close	to	zero	but	which	may	differ	from	;0 .	Since	all	;0 	and	;0q	are	infinitesimally	small,	their	precise	values	have	no	impact	upon	the	overall	model	dynamics.	In	the	transitions	above,	we	have	been	able	to	classify	all	potential	host	states	after	events	occur	as	one	of	the	original	five	host	states,	so	these	five	host	states	are	sufficient	to	capture	the	full	dynamics	of	the	individual-based	model.		Finally,	it	is	a	property	of	the	Poisson	distribution	that	when	t0	~	Poisson(z0)	for	all	i,	t00 	~	Poisson( z00 ).	In	other	words,	an	event	which	happens	at	rate	z	to	individual	hosts	of	type	A	will	happen	at	rate	5{z	to	all	hosts	of	type	A	collectively.			Taking	this	all	together,	over	a	sufficiently	small	period	of	time	∆t,	such	that	only	one	event	occurs	within	the	period,	transitions	(S1)	will	have	the	following	impact	upon	the	number	of	hosts	of	each	type:			 	 										Δ57 = |6→7 − |7→6 − |7→79		 	 										Δ58 = |6→8 − |8→6 − |8→8< + |79→8 + |8<→8		 	 										Δ579 = |7→79 − |79→6 − |79→8		 	 										Δ58< = |8→8< − |8<→6 − |8<→8		 	 										Δ56 = −Δ57 − Δ58 − Δ579 − Δ58<	,	 	 (S2)	
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where	 |6→7	~	Poisson ? 57 + 5795 56Δ. 	|7→6	~	Poisson } + ~ 57Δ. 	|7→79	~	Poisson k ? 1 − E 58 + 58<5 57Δ. 	|6→8	~	Poisson ? 1 − E 58 + 58<5 56Δ. 	|8→6	~	Poisson }5Δ. 	|8→8<	~	Poisson k ? 57 + 5795 58Δ. 	|79→8	~	Poisson ~579Δ. 	|8<→8	~	Poisson ~58<Δ. 	|79→6	~	Poisson }579Δ. 	|8<→6	~	Poisson }58<Δ. 	.		 	 	 	 	 	 	 	 	 (S3)		This	is	the	stochastic,	finite-population,	individual-based	analogue	of	the	deterministic,	infinite-population,	ODE-based	mixed-carriage	model.	To	see	this,	substitute	variates	(S3)	into	equations	(S2),	divide	both	sides	by	5Ä.,	and	make	a	change	of	variables	such	that	Å = G<G , Ç = G9G , Å = G<9G , ÇÉ = G9<G ,	and	t = GÑG .	Also,	allow	the	population	size	N	to	go	to	infinity,	which	permits	replacing	all	variates	of	the	form	|{→Ö	~	Poisson Ü{→ÖΔ. ,	where	A	and	B	are	any	two	host	types,	with	their	expected	values,	E |{→Ö = Ü{→ÖΔ..	(For	example,	replace	|8<→6	~	Poisson }58<Ä. 	with	E |8<→6 = }58<Δ..)	This	yields			 UÉUV = ? Å + Å t − } + ~ Å − k? 1 − E Ç + ÇÉ Å			 UUV = ? 1 − E Ç + ÇÉ t − }Ç − k? Å + Å Ç + ~(Å + ÇÉ)			 UÉàUV = k? 1 − E Ç + ÇÉ Å − } + ~ Å 		 UâUV = k? Å + Å Ç − } + ~ ÇÉ		 t = 1 − Å − Ç − Å − ÇÉ	.	 		By	taking	the	limit	as	Ä. → 0,	this	gives	the	mixed-carriage	ODE	model	implementation,			 äÉäV = ?Åãåãt − } + ~ Å − k? 1 − E ÇãåãÅ		 ääV = ? 1 − E Çãåãt − }Ç − k?ÅãåãÇ + ~(Å + ÇÉ)			 äÉàäV = k? 1 − E ÇãåãÅ − } + ~ Å 		 äâäV = k?ÅãåãÇ − } + ~ ÇÉ		 t = 1 − Å − Ç − Å − ÇÉ	.	 		Therefore,	the	individual-based	and	ODE	implementations	are	equivalent	under	the	stipulated	limiting	assumptions.	The	equivalence	of	the	two	implementations	of	the	 	
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Fig.	S1	|	Schematic	of	within-host	strain	growth.	Carriage	compartments	(filled	blue	circles)	in	the	ODE	approximation	of	the	mixed-carriage	model	with	differential	within-host	strain	growth.	Compartments	between	RS	and	SR	are	equally	spaced	along	a	logistic	curve	(dashed	red	line).	The	“growth	model”	curve	(solid	black	line)	was	generated	by	the	individual-based	model	and	also	defines	a	logistic	curve.	The	transition	from	R	to	RS	occurs	via	transmission	of	the	sensitive	strain	at	rate	kls,	transitions	between	compartments	RS,	DZ,	DZ–1,	...,	D1,	and	SR	occur	via	within-host	strain	growth	at	rate	b,	and	the	final	transition	from	SR	to	S	occurs	at	rate	b0.	Additionally,	a	transition	from	S	“back”	to	SR	may	occur	via	transmission	of	the	resistant	strain	at	rate	klr.			knockout	model	can	be	seen	in	a	similar	way,	noting	that	each	transition	specified	by	the	individual-based	implementation	corresponds	to	a	term	in	the	ODE	implementation,	which	makes	the	implementations	equivalent	when	the	population	size	N	is	very	large.		
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shows	that	the	logistic	curve	used	by	the	ODE	implementation	is	indistinguishable	from	the	explicit	growth	model	used	by	the	individual-based	implementation.	Note	that	as	the	number	of	intermediate	compartments	Z	approaches	infinity,	the	relationship	between	
b	and	ws	is	approximately	ë = − í + 1 ìåîïZìåî \ 	.		
1.3	Within-host	competitive	exclusion		Because	we	assume	within-host	strain	growth	is	exponential,	it	would	be	technically	possible	for	the	resistant	strain	to	be	driven	to	lower	and	lower	within-host	frequencies	by	the	growth	of	the	sensitive	strain,	and	yet	never	reach	zero	frequency.	This	might	be	undesirable,	as	it	could	result	in	a	situation	where	antibiotic	treatment	eliminates	the	sensitive	strain	from	carriage	and	allows	the	resistant	strain	to	completely	take	over	the	host	in	spite	of	the	within-host	frequency	of	the	resistant	strain	being	extremely	low—possibly	so	low	that	it	would	correspond	to	less	than	a	single	cell.	This	could	unfairly	promote	coexistence,	because	it	would	effectively	allow	the	frequency-dependent	advantage	of	resistant	strains	to	remain	the	same	regardless	of	the	relative	growth	rate	of	the	sensitive	strain.	To	avoid	this	unrealistic	scenario,	we	stipulate	that	strains	below	a	certain	within-host	frequency	are	eliminated	completely.	In	the	individual-based	model	implementation,	this	is	done	using	the	parameter	!"#$—any	strain	whose	within-host	frequency	falls	below	this	value	is	eliminated	during	the	host	“updating”	step	(see	Methods).	To	control	this	behaviour	in	the	ODE	model	implementation,	we	use	the	parameter	b0,	which	determines	how	quickly	resistant	cells	are	eliminated	from	SR	carriers	(because	it	is	the	rate	of	the	transition	from	host	state	SR	to	host	state	S).	In	the	individual-based	mixed-carriage	model,	we	assume	that	!"#$ = 3×10Jò,	which	means	that	strains	are	eliminated	once	they	reach	3%	of	the	germ	size,	, = 0.001.			In	order	to	match	this	behaviour	in	the	ODE	implementation,	we	set	ëô = Iö ë.	This	corresponds	approximately	to	!"#$ = 3×10Jò	for	the	following	reasons.	First,	recall	(Methods)	that	the	proportion	of	a	host’s	carried	cells	that	are	resistant		 3õú = 11 + exp ü a 	,		where	ü a = log , ö¢£HI − 1 ,	v	is	the	ODE	compartment	number	(Fig.	S1),	and	Z	is	the	number	of	intermediate	compartments.	Note	that	we	have	3õú = 3.16×10Jò	when	a =−2,	, = 0.001,	and	í = 7	(we	assume	, = 0.001	and	Z	=	7	throughout	the	paper).	That	is,	starting	from	the	SR	compartment	(equivalent	to	compartment	a = 0)	on	Fig.	S1,	if	we	assume	it	takes	two	additional	“growth	steps”	to	the	right	in	order	to	completely	eliminate	the	resistant	strain	and	reach	the	S	compartment,	this	takes	us	to	a	resistant-strain	frequency	of	about	3õú = 3×10Jò.	It	takes	twice	as	long	to	take	two	steps	as	it	does	to	take	one	step,	which	is	why	we	assume	the	rate	of	this	SR	to	S	transition	is	equal	to	half	the	normal	rate,	i.e.	ëô = Iö ë.		This	still	leaves	the	question	open	as	to	whether	our	chosen	value	of	!"#$ = 3×10Jò	is	realistic.	However,	the	minimum	infective	dose	for	S.	pneumoniae	has	been	estimated	to		 	
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Germ	size	—	Another	difference	between	the	knockout	model	and	the	mixed-carriage	model	is	that	the	knockout	model	assumes	that	a	successfully	co-colonising	strain	reaches	a	within-host	frequency	of	1/2,	while	the	mixed-carriage	model	assumes	that	co-colonising	strains	are	initially	present	at	a	within-host	frequency	of	,/(1 + ,).	This	might	potentially	impact	upon	the	relative	extent	of	coexistence	shown	by	each	model.	However,	as	we	show	in	Fig.	S3d,	when	we	set	, = 1	in	the	mixed-carriage	model	(making	the	within-host	frequency	of	newly	co-colonised	strains	1/2,	the	same	as	in	the	knockout	model)	there	is	almost	no	impact	upon	the	potential	for	coexistence.	 	
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Mixed-carriage model (equal growth) Mixed-carriage model (differential growth)
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Fig.	S5	illustrates	more	directly	the	relationship	between	the	frequency	of	dual	carriage	and	the	amount	of	coexistence.	We	constructed	this	figure	by	fitting	the	mixed-carriage	model	with	differential	within-host	growth	for	a	fixed	?	and	u	(? = 2, } = 1	for	S.	
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3.1	Structural	neutrality	of	the	mixed-carriage	model		Intuitively,	a	structurally-neutral	model	is	one	in	which,	when	multiple	equivalent	strains	are	being	analysed,	all	model	dynamics	are	essentially	unbiased	with	respect	to	the	identities	of	the	strains	being	analysed,	such	that	the	model	dynamics	are	governed	entirely	by	unbiased	random	sampling	of	individual	pathogens	(i.e.,	by	drift).		Suppose	that	two	equivalent	strains,	A	and	B,	were	analysed	with	the	knockout	model.	Since	these	strains	are	equivalent,	assume	without	loss	of	generality	that	they	are	both	unaffected	by	antibiotic	treatment.	Alternatively,	they	could	both	be	affected	by	antibiotic	treatment,	which	then	becomes	indistinguishable	from	an	inflated	rate	of	natural	clearance,	}q = } + ~.	In	the	knockout	model,	when	a	non-carrier	is	colonised,	the	probability	that	it	becomes	colonised	with	strain	A	is	equal	to	the	relative	frequency	of	strain	A	in	the	population,	while	the	probability	that	it	instead	becomes	colonised	with	strain	B	is	equal	to	the	relative	frequency	of	strain	B	in	the	population.	Therefore,	colonisation	is	neutral	with	respect	to	strain	identities.	When	a	carrier	is	co-colonised,	the	contents	of	one	of	its	two	subcompartments	is	replaced	with	either	strain	A	or	strain	B,	again	proportionally	to	the	relative	frequency	of	that	strain	in	the	population.	Accordingly,	co-colonisation	is	also	neutral	with	respect	to	strain	identities.	Finally,	carriers	undergo	natural	clearance	irrespective	of	the	actual	strains	they	are	carrying	in	either	subcompartment,	so	clearance	is	also	neutral	with	respect	to	strain	identities.	In	summary,	when	analysing	equivalent	strains,	the	knockout	model’s	dynamics	are	governed	entirely	by	drift,	which	shows	that	the	knockout	model	is	structurally	neutral.		The	mixed-carriage	model	is	structurally	neutral	for	similar	reasons.	Suppose	we	were	to	use	the	mixed-carriage	model	to	analyse	equivalent	strains.	This	requires	that	we	assume	no	differential	within-host	growth	and	that	!"#$ = &"#$ = 0	to	prevent	strain	identities	from	having	any	impact	upon	model	dynamics.	Then,	colonisation	is	neutral	with	respect	to	strain	identities	because	when	a	non-carrier	is	colonised,	the	strain	they	are	colonised	with	is	chosen	with	probability	equal	to	its	population-level	frequency.	Co-colonisation	is	also	neutral	because	it	replaces	a	fraction	,/(1 + ,)	of	cells	in	a	carrier	with	cells	of	a	random	strain,	also	chosen	with	probability	equal	to	that	strain’s	
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population-level	frequency.	And	clearance	is	neutral	because	hosts	experience	clearance	events	independently	of	the	mix	of	strains	they	are	carrying.	For	that	reason,	when	analysing	equivalent	strains,	the	mixed-carriage	model	is	governed	entirely	by	drift	and	is	therefore	structurally	neutral.		This	argument	can	be	made	more	rigorous.	We	argue	below	that	the	mixed-carriage	model	meets	the	two	criteria	for	structural	neutrality	proposed	by	Lipsitch	et	al.3—“ecological	neutrality”	and	“population-genetic	neutrality”—and	hence	is	structurally	neutral.			3.1.1	Ecological	neutrality		In	order	for	a	model	to	be	ecologically	neutral	for	identical	strains,	it	must	be	possible	to	rewrite	the	model	in	terms	of	“ecological	state	variables”—namely,	the	number	of	uninfected	hosts	and	the	number	of	hosts	that	have	been	colonised	0,	1,	2,	etc.,	times—in	a	way	which	is	independent	of	identities	of	any	particular	strains	involved3.	To	meet	the	assumption	of	indistinguishable	strains,	we	set	E = 0,	~ = 0	and	)* = 1,	and	in	order	to	prevent	neutral	labels	from	having	an	impact	upon	strain	dynamics,	we	assume	that	!"#$ = &"#$ = 0.	Now	note	that	we	can	rewrite	the	mixed-carriage	model	as	a	series	of	transitions	between	host	states	5ô, 5I, 5ö, …	defined	by	the	subscript	M,	the	multiplicity	of	infection	(i.e.,	the	total	number	of	colonisations	experienced	by	a	specific	host	since	their	last	episode	of	natural	clearance):		 5ô 	Y≤≥≤	 5I				(colonisation)	5µ 	lY≤≥≤	 5µHI				for	all	∑ > 0				(co-colonisation)	5µ e 5ô				for	all	∑ > 0				(clearance)	,		where	>ãåã = ?(5I + 5ö + ⋯+ 5)	is	the	total	force	of	infection	in	the	population.	This	is	enough	to	fully	specify	the	model	if	we	are	indifferent	to	the	identities	of	the	indistinguishable	strains	that	are	circulating.			Note	that	the	within-host	frequency	fm	attributable	to	the	mth	colonising	strain	in	a	host	that	has	been	colonised	M	times	is			 !I = 11 + , µJI	,	!∫ = ,1 + , µJ∫HI 		for	all	b ≥ 2.		3.1.2	Population-genetic	neutrality		In	order	for	a	model	with	two	strains	to	meet	the	criterion	of	population-genetic	neutrality,	the	expected	frequency	of	either	strain	should	not	change	over	time	if	the	two	strains	are	identical	apart	from	a	biologically-meaningless	label3.	For	the	mixed-carriage	model,	this	means	that	both	strains	will	have	equal	within-host	fitness	(meaning	that	within-host	growth	can	be	neglected;	see	above)	and	either	that	both	
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strains	are	resistant	(in	which	case	treatment	has	no	effect,	so	we	can	assume	~ = 0)	or	both	strains	are	sensitive	(in	which	case	treatment	and	natural	clearance	can	be	treated	together	as	clearance	at	rate	}q = } + ~).	We	will	also	assume	!"#$ = 0	and	&"#$ = 0.			Since	we	are	free	to	ignore	treatment	and	within-host	growth,	this	means	that	the	only	changes	to	a	given	population	will	occur	through	a	random	sequence	of	transmission	and	clearance	events.	Let	us	refer	to	the	two	strains	of	the	model	as	strain	A	and	strain	B.	Each	random	clearance	or	transmission	event	will	cause	a	small	perturbation	to	the	frequency	of	strain	A,	and	an	equal	and	opposite	perturbation	to	the	frequency	of	strain	B.	Our	aim	here	is	twofold.	First,	we	will	show	that	the	expected	value	of	these	perturbations	to	the	frequency	of	strain	A	is	zero	for	each	type	of	event	regardless	of	the	state	of	the	population.	In	doing	so,	we	will	show	that	the	mixed-carriage	model	does	not	favour	either	strain	A	or	B	arbitrarily.	Second,	we	will	show	that	the	magnitude	(i.e.	absolute	value)	of	any	such	perturbation	goes	to	zero	as	the	number	of	carriers	goes	to	infinity.	This	shows	that	as	the	total	population	size	goes	to	infinity,	the	combined	effect	of	all	transmission	and	clearance	events	in	a	fixed	time	period	goes	to	zero,	and	hence	the	mixed-carriage	model	satisfies	population-genetic	neutrality,	suggesting	that	any	stochastic	fluctuations	for	a	finite	population	are	attributable	to	drift.		Suppose	that	there	are	N	hosts	in	total,	K	of	which	are	carriers	(the	remaining	N	–	K	are	non-carriers).	Of	the	K	carriers,	the	ith	carrier’s	carriage	of	strain	A	is	z0 	and	their	carriage	of	strain	B	is	1 − z0 .	The	overall	frequency	of	strain	A	in	the	population	is	t =Iª z0ª0ºI ,	while	the	total	carriage	of	strain	A	is	Ωt = z0ª0ºI ;	note	that	X	is	also	the	expected	value	of	z0 	for	a	random	carrier,	since	E z0 = Iª z0ª0ºI = Iª z0ª0ºI = t.	If	the	frequency	of	strain	A	before	some	event	is	X,	and	the	frequency	of	strain	A	following	the	event	is	tq,	our	aim	is	(1)	to	show	that	E tq = t	for	both	clearance	and	transmission	events	and	(2)	that	the	magnitude	of	any	of	these	perturbations	is	inversely	proportional	to	the	number	of	carriers,	i.e.	|tq − t| ∝ Iª.		
Clearance	—	When	clearance	occurs,	a	random	carrier	j	has	their	carriage	eliminated,	which	means	the	number	of	carriers,	K,	decreases	by	1	and	the	total	population	carriage	of	strain	A,	KX,	decreases	by	z¿ .	Therefore,	the	expected	frequency	of	strain	A	following	a	clearance	event	is		 E tq = E Ωt − z¿Ω − 1 	= Ωt − E z¿Ω − 1 	= Ωt − tΩ − 1 	= Ω − 1 tΩ − 1 = t,		
i.e.	clearance	leaves	the	expected	frequency	of	strain	A	unchanged.	Note	that	any	one	clearance	event	changes	the	frequency	of	strain	A	by		
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Ωt − z¿Ω − 1 − t	= t − z¿Ω − 1 	,		which	goes	to	zero	as	Ω →.			
Transmission	—	There	are	two	types	of	transmission	events:	transmission	events	which	result	in	the	colonisation	of	uncolonised	hosts,	and	transmission	events	which	result	in	the	colonisation	of	already-colonised	hosts.	For	the	first	type	of	transmission	event,	the	probability	that	strain	A	is	being	transmitted	is	X	and	the	probability	that	strain	B	is	being	transmitted	is	1	–	X.	The	outcome	is	that	an	extra	carrier	is	added,	such	that	the	total	number	of	carriers	becomes	K	+	1,	and	the	new	carrier	is	a	strain-A	carrier	with	probability	X	(increasing	total	carriage	of	strain	A	by	1)	and	a	strain-B	carrier	with	probability	1	–	X	(keeping	total	carriage	of	strain	A	the	same).	Therefore	the	expected	frequency	of	strain	A	following	a	transmission	event	to	an	uncolonised	host	is		 E tq = t Ωt + 1Ω + 1 + (1 − t) ΩtΩ + 1 	= Ωtö + t + Ωt − ΩtöΩ + 1 	= t Ω + 1Ω + 1 = t	,		
i.e.	transmission	to	an	uncolonised	host	leaves	the	expected	frequency	of	strain	A	unchanged.	Note	that	any	single	transmission	to	an	uncolonised	host	changes	the	frequency	of	strain	A	by		 Ωt + 1Ω + 1 − t	= 1 − tΩ + 1		if	strain	A	is	being	transmitted	and		 ΩtΩ + 1 − t	= − tΩ + 1		if	strain	B	is	being	transmitted,	which	both	go	to	zero	as	Ω →.		Finally,	if	a	carrier	j	experiences	a	transmission	event,	their	carriage	of	strain	A	will	change	from	z¿ 	to	¡¬H\IH\ 	if	strain	A	is	being	transmitted	and	to	 ¡¬IH\	if	strain	B	is	being	transmitted,	where	,	is	the	germ	size.	Equivalently,	carrier	j’s	carriage	of	strain	A	changes	by		¡¬H\IH\ − z¿ = \IH\ (1 − z¿)	with	probability	X,	and	changes	by	 ¡¬IH\ − z¿ = − \IH\ z¿ 		with	probability	1	–	X.	If	a	single	carrier’s	strain-A	carriage	changes	by	some	amount	y,	
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then	the	population	frequency	of	A	changes	by	y/K;	overall,	the	expected	population-level	frequency	of	strain	A	following	a	transmission	event	to	a	colonised	host	is		 E tq = E t t + ,1 + , 1 − z¿Ω 	 + 1 − t t − ,1 + , 	z¿Ω 	= t t + ,1 + , 1 − E(z¿)Ω 	 + 1 − t t − ,1 + , 	E(z¿)Ω 	= t t + ,1 + , 1 − tΩ 	 + 1 − t t − ,1 + , 	 XΩ 	= tö + ,1 + , t(1 − t)Ω + t − tö − ,1 + , t(1 − t)Ω = t	,		




Fig.	S6	|	Dynamics	of	the	ODE	implementation	of	the	mixed-carriage	model.	Top	row:	Model	dynamics	for	the	mixed-carriage	ODE	model	where	the	S	strain	and	R	strain	are	equivalent.	That	is,	we	have	~ = 0, E = 0,	and	ë = 0.	Other	parameters	are	? = 5, } = 1,	and	k = 1.	Each	panel	of	the	top	row	shows	the	same	parameters	but	different	initial	frequencies	of	S	and	R	carriers.	Note	that	the	relative	prevalence	of	the	R	strain—i.e.	(Ç + ÇÉ) (Ç + ÇÉ + Å + Å)—stays	constant	over	time,	remaining	equal	to	initial	prevalence	at	t	=	0	as	shown	in	the	figure	headings.	Bottom	row:	example	dynamics	for	non-equivalent	strains	are	illustrated.	These	correspond	to	Fig.	3f	of	the	main	text,	i.e.	? = 5, E = 0.124, ë = 0, k = 1, } = 1,	and	~	as	given	in	the	figure	heading.			possibility	is	that	hosts	comprise	a	single	niche,	and	SR	carriers	represent	hosts	in	which	the	niche	carries	half	resistant	cells	and	half	sensitive	cells.	This	interpretation	is	incompatible	with	structural	neutrality,	because	even	when	S	cells	and	R	cells	only	differ	by	a	biologically-meaningless	marker,	they	are	eliminated	en	bloc	during	knockout.		In	summary,	we	argue	that	the	knockout	model	cannot	simultaneously	be	used	to	model	transmission	dynamics	among	hosts	capable	of	carrying	a	large	number	of	diverse	pathogens	in	the	same	niche,	while	also	adhering	to	the	motivating	concept	of	structural	neutrality	which	dictates	that	model	dynamics	should	not	be	influenced	by	a	neutral	label	applied	to	some	subset	of	pathogens.	We	suggest	that	models	incorporating	within-host	dynamics	should	endeavour	to	treat	individual	pathogens	(whether	microbes,	viruses,	or	macroparasites)	neutrally,	rather	than	only	treating	strains	neutrally. 	
Equivalent strains, R(0) = .002, S(0) = .008 Equivalent strains, R(0) = .004, S(0) = .006 Equivalent strains, R(0) = .006, S(0) = .004 Equivalent strains, R(0) = .008, S(0) = .002
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pneumoniae,	we	assume	an	average	duration	of	carriage	of	1	month	for	consistency	with	previous	studies2,8,	while	for	E.	coli,	we	assume	that	the	average	duration	of	carriage	is	59	to	98	days9,10,	and	accordingly	set	a	uniform	prior	for	u	over	the	range	0.3–0.5	months-1.	The	transmission	rate	b	is	indirectly	constrained	by	a	likelihood	penalty	on	prevalence	of	carriage,	so	we	set	a	uniform	prior	for	b	wide	enough	to	overlap	the	full	range	of	permissible	carriage	prevalence,	Y,	given	the	range	of	clearance	rates	u	and	treatment	rates	τ	(i.e.	& = 1 − (} + ~)/?	for	the	sensitive	strain	alone,	and	& = 1 −}/ ? 1 − E 	for	the	resistant	strain	alone).					
E.coli	/	Aminopenicillins:	5	parameters	 E.	coli	/	Fluoroquinolones:	5	parameters	 S.	pneumoniae	/	Macrolides:	4	parameters	 S.	pneumoniae	/	Penicillins:	4	parameters		 Fitted	parameters	
 
 ?	(transmission	rate)		 0.75	–	10	mo–1	 0.75	–	10	mo–1	 1	–	6	mo–1	 1	–	6	mo–1	
c	(transmission	cost	of	resistance:	knockout	&	equal-growth	mixed-carriage	models	only)	 0	–	1	 0	–	1	 0	–	1	 0	–	1	
	
b	(within-host	growth	benefit	of	sensitivity:	differential-growth	mixed-carriage	model	only)	 0	–	10	 0	–	10	 0	–	10	 0	–	10	
	
k	(relative	efficiency		of	co-colonisation)	 0	–	1	 0	–	1	 0	–	1	 0	–	1	
	
u	(natural	clearance	rate)	 0.3	–	0.5	mo–1	 0.3	–	0.5	mo–1	 fixed	(1	mo–1)	 fixed	(1	mo–1)	
 ƒ	(additional	between-country	variability	in	resistance	prevalence)	 0	–	1	 0	–	1	 0	–	1	 0	–	1	
	 Likelihood	components	
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pneumococcal	serotypes	in	the	absence	of	adaptive	immunity.		Here,	we	provide	details	of	the	“extended”	mixed-carriage	model	that	can	accommodate	any	number	of	strains.	In	this	individual-based	model	implementation,	there	are	N	hosts,	L	serotypes,	and	M	=	2L	strains.	The	frequency	of	host	i’s	carriage	of	strain	j	is	!0,¿ ,	and	a	host’s	total	carriage	is	∆0 = !0,¿¿ .	We	assume	that	strains	1	and	2	are	of	serotype	1,	strains	3	and	4	are	of	serotype	2,	strains	5	and	6	are	of	serotype	3,	and	so	on,	and	that	odd-numbered	strains	are	sensitive	while	even-numbered	strains	are	resistant.	Two	different	kinds	of	process	act	upon	hosts:	“updates”	to	within-host	growth	occur	at	discrete	time	intervals	of	∆t	=	0.001,	while	transmission,	clearance,	and	treatment	events	are	Poisson	processes	that	occur	at	random	times	between	updates.		During	updating,	any	strains	which	have	a	frequency	of	less	than	fmin	are	cleared;	then	each	strain	in	each	carrier	grows	by	a	factor	M¿ = )¿UV ,	where	wj	is	strain	j’s	per-unit-time	within-host	growth	rate;	then	each	carrier’s	total	carriage	is	normalised	so	that	∆0 = 1.	That	is,		 !0,I, !0,ö, … , !0,µ → MIN !0,IM¿N(!0,¿)¿ , MöN !0,öM¿N(!0,¿)¿ , … , MµN !0,µM¿N(!0,¿)¿ 	,		where		 N P = P if	P ≥ !"#$0 if	P < !"#$	.		Note	that	if	all	carried	strains	have	a	frequency	of	less	than	fmin,	then	the	right-hand	side	of	the	transition	notated	above	evaluates	to	 ôô , ôô , … , ôô .	In	this	case,	we	set	a	host’s	state	to	 0,0, … ,0 .		The	force	of	infection	for	each	strain	j	is	>¿ = ?¿ max &"#$, !0,¿0 /5	(we	can	set	&"#$ =1	to	effectively	assume	there	is	always	at	least	one	carrier	of	each	strain	in	order	to	avoid	stochastic	elimination	of	strains13,	or	set	&"#$ = 0	to	not	do	this).	Here,	?¿ 	is	the	transmission	rate	for	strain	j,	including	any	transmission-rate	penalty	for	resistance—that	is,	for	a	two-strain	model	with	a	sensitive	and	a	resistant	strain,	we	could	write	?I = ?, ?ö = ?(1 − E).	Events	comprise	transmission	events,	clearance	events,	and	treatment	events.	Specifically:	transmission	events	for	each	strain	j	occur	at	rate	j0>¿ 	to	each	host,	where	j0 = 1	if	∆0 = 0	and	j0 = k	if	∆0 > 0;	clearance	events	for	each	serotype	ℓ	occur	at	rate	}ℓ	to	each	host,	where	}ℓ	is	the	clearance	rate	for	serotype	ℓ;	and	
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equilibrium,	rather	than	a	transient	phase	on	the	way	to	competitive	exclusion.		In	Fig.	1d	of	the	main	text,	we	argue	that	observed	intermediate	resistance	prevalences	reflect	stable	coexistence	between	sensitive	and	resistant	strains,	rather	than	a	transient	phase	on	the	way	to	competitive	exclusion,	because	average	resistance	prevalence	in	the	four	pathogen-drug	combinations	we	are	investigating	has	essentially	not	changed	from	2007–2015.	The	average	resistance	prevalence	in	Europe	for	2007–2015	was	calculated	as	a	weighted	mean	of	the	resistance	prevalence	for	each	country14,15—with	resistance	prevalence	sampled	1000	times	from	a	beta	distribution	with	parameters	Ü = 3 + 1, ? =_ + 1 − 3	(i.e.	assuming	a	uniform	prior	for	the	underlying	binomial	probability)—each	time	weighted	by	the	population	of	the	country	in	the	corresponding	year,	across	only	those	countries	reporting	resistance	data	for	all	years	in	2007–2015,	which	left	ca.	20	countries	in	each	pathogen-drug	data	set.		Another	way	of	looking	at	this	question	is	to	ask	whether	high	consumption	in	a	given	year	tends	to	predict	a	large	increase	in	resistance	in	the	following	year.	Looking	at	each	European	country	in	the	data	set	from	2007–2015,	there	is	a	clear	trend	that	penicillin	consumption	in	a	given	year	strongly	predicts	the	percentage	of	S.	pneumoniae	isolates	testing	as	non-susceptible	in	that	year	(Fig.	S13a).	However,	having	high	consumption	in	a	given	year	is	not	significantly	associated	with	an	increase	in	penicillin	non-susceptibility	into	the	next	year	(Fig.	S13b)	or	two	years	hence	(Fig.	S13c).	This	seeming	lack	of	a	temporal	relationship	does	not	appear	to	be	explained	by	countries	with	high	consumption	decreasing	their	consumption	in	further	years,	as	there	is	no	significant	relationship	between	current	consumption	and	the	change	in	consumption	in	the	following	year	(Fig.	S13d).	Taken	together,	this	suggests	that	the	response	of	resistant	strains	to	antibiotic	use	may	be	relatively	fast.		 	
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E.coli 	/	Aminopenicillins E.	coli 	/	Fluoroquinolones S.	pneumoniae 	/	Macrolides S.	pneumoniae 	/	PenicillinsMODELKnockout 426.2 411.9 253.6 217.3Mixed-carriage
equal	growthMixed-carriage
differential	growth
Knockout 418.9 406.9 245.3 208.2Mixed-carriage
equal	growthMixed-carriage
differential	growth
E.coli 	/	Aminopenicillins E.	coli 	/	Fluoroquinolones S.	pneumoniae 	/	Macrolides S.	pneumoniae 	/	PenicillinsMODELKnockout 416.2–422.6 404.4–408.3 247.9–251.4 209.3–216.3Mixed-carriage
equal	growthMixed-carriage
differential	growth
Knockout 409.1–414.1 396.9–405.6 239.5–243.2 200.3–209.1Mixed-carriage
equal	growthMixed-carriage
differential	growth









We	use	AIC	in	the	main	text	to	formally	assess	model	fit.	Deviance,	defined	as	–2L ,	where	L 	is	the	likelihood,	is	an	alternative	way	of	assessing	model	fit.	Deviance	provides	a	distribution	rather	than	a	single	value,	which	some	readers	may	prefer.	We	provide	the	AIC	and	the	95%	HDI	for	deviance	below,	for	both	the	case	of	0	≤	k 	≤	1	(main	text)	and	0	≤	k 	≤	5	(Supplementary	Note	2).









w b w b1 30 3.2 24 2.88 0.2180406212 29 3.2 23.2 2.88 0.2285249193 28 3.2 22.4 2.88 0.249316944 27 3.2 21.6 2.88 0.2816358025 26 3.2 20.8 2.88 0.310374156 25 3.2 20 2.88 0.3132509447 24 3.2 19.2 2.88 0.3138974898 23 3.2 18.4 2.88 0.32427159 22 3.2 17.6 2.88 0.3413767310 21 3.2 16.8 2.88 0.3425300311 20 3.2 16 2.88 0.34682630212 19 3.2 15.2 2.88 0.3574226413 18 3.2 14.4 2.88 0.39298018914 17 3.2 13.6 2.88 0.40393979615 16 3.2 12.8 2.88 0.41214995516 15 3.2 12 2.88 0.41496134617 14 3.2 11.2 2.88 0.4499506918 13 3.2 10.4 2.88 0.47975814919 12 3.2 9.6 2.88 0.49138395320 11 3.2 8.8 2.88 0.52715193521 10 3.2 8 2.88 0.53550469522 9 3.2 7.2 2.88 0.54026050923 8 3.2 6.4 2.88 0.5510265724 7 3.2 5.6 2.88 0.55303030325 6 3.2 4.8 2.88 0.56119311226 5 3.2 4 2.88 0.56536555127 4 3.2 3.2 2.88 0.60350529128 3 3.2 2.4 2.88 0.68660647129 2 3.2 1.6 2.88 0.74917898230 1 3.2 0.8 2.88 0.777919864
u
Serotype-specific	parameters	used	for	the	individual-based	model	runs	parameterised	with	30	serotypes.	The	serotype-specific	clearance	rates	(u )	are	derived	from	an	infant	pneumococcal	carriage	study	(see	Lehtinen	et	al., 	2017,	for	data	source).
Serotype	(fitness	rank) Sensitive	strain Resistant	strain
